STAAR Surgical Net Worth

STAAR Surgical Net Worth Breakdown

  STAA
The net worth of STAAR Surgical is the difference between its total assets and liabilities. STAAR Surgical's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of STAAR Surgical's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. STAAR Surgical's net worth can be used as a measure of its financial health and stability which can help investors to decide if STAAR Surgical is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in STAAR Surgical stock.

STAAR Surgical Net Worth Analysis

STAAR Surgical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including STAAR Surgical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of STAAR Surgical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform STAAR Surgical's net worth analysis. One common approach is to calculate STAAR Surgical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares STAAR Surgical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing STAAR Surgical's net worth. This approach calculates the present value of STAAR Surgical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of STAAR Surgical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate STAAR Surgical's net worth. This involves comparing STAAR Surgical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into STAAR Surgical's net worth relative to its peers.
To determine if STAAR Surgical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STAAR Surgical's net worth research are outlined below:
STAAR Surgical generated a negative expected return over the last 90 days
STAAR Surgical has high historical volatility and very poor performance
The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 239.58 M.
STAAR Surgical has a strong financial position based on the latest SEC filings
Over 100.0% of the company shares are owned by institutional investors
STAAR Surgical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STAAR Surgical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STAAR Surgical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Follow STAAR Surgical's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 868.87 M.

Project STAAR Surgical's profitablity

The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.57.
When accessing STAAR Surgical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures STAAR Surgical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STAAR Surgical's profitability and make more informed investment decisions.
Please note, the presentation of STAAR Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STAAR Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on STAAR Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STAAR Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Farrell Stephen C 3 days ago
Disposition of 10000 shares by Farrell Stephen C of STAAR Surgical at 5.54 subject to Rule 16b-3
 
Patrick Williams over a week ago
Disposition of 4061 shares by Patrick Williams of STAAR Surgical subject to Rule 16b-3
 
Butcher Arthur C over a week ago
Acquisition by Butcher Arthur C of 4010 shares of STAAR Surgical at 40.11 subject to Rule 16b-3
 
Farrell Stephen C over a week ago
Disposition of 10000 shares by Farrell Stephen C of STAAR Surgical at 8.35 subject to Rule 16b-3
 
Broadwood Partners, L.p. over two weeks ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Broadwood Partners, L.p. over two months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Thomas Frinzi over two months ago
Disposition of 10775 shares by Thomas Frinzi of STAAR Surgical at 24.54 subject to Rule 16b-3
 
Broadwood Partners, L.p. over three months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Broadwood Partners, L.p. over three months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Broadwood Partners, L.p. over three months ago
Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3
 
Patrick Williams over three months ago
Acquisition by Patrick Williams of 24460 shares of STAAR Surgical subject to Rule 16b-3
 
Broadwood Partners, L.p. over six months ago
Acquisition by Broadwood Partners, L.p. of 87849 shares of STAAR Surgical at 35.641 subject to Rule 16b-3
STAAR Surgical time-series forecasting models is one of many STAAR Surgical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary STAAR Surgical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

STAAR Surgical Earnings per Share Projection vs Actual

When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.